High doses of dexamethasone (1-12 mg/kg twice daily) were administered to pregnant rats for 2 days. The effect of dexamethasone on fetal and maternal lung prostaglandin metabolism was examined on day 21 of gestation. Dexamethasone treatment at all dosages significantly increased conversion of [14C]-arachidonic acid to 6-ketoprostaglandin Fα in both fetal and maternal lung homogenates. This finding is similar to our earlier finding using lower dosages of dexamethasone and suggests that dexamethasone enhances lung prostaglandin synthetase activity. Because dexamethasone is known to inhibit the activity of phospholipases, we also measured lung immunoreactive 6-ketoprostaglandin Fα. The results showed that dexamethasone treatment did not diminish lung 6-keto-prostaglandin F1α level even at the highest dosage used (12 mg/kg). These results suggest that high dosages of dexamethasone, such as those used in the clinical treatment of septic shock, do not inhibit synthesis of lung prostaglandin.
|Original language||English (US)|
|Number of pages||7|
|Journal||Prostaglandins, Leukotrienes and Medicine|
|State||Published - Jul 1987|
Bibliographical noteFunding Information:
This work was supported in part by grants from the Viking Children's Fund and the American Diabetes Association, Minnesota Affiliate. I thank Cynthia Jones for her excellent technical assistance.
Copyright 2014 Elsevier B.V., All rights reserved.